These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 2418395

  • 1. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
    Einhorn N, Bast RC, Knapp RC, Tjernberg B, Zurawski VR.
    Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
    [Abstract] [Full Text] [Related]

  • 2. [Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].
    Crombach G, Zippel HH, Würz H.
    Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):205-12. PubMed ID: 2408962
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of CA 125 levels in differentiating malignant from benign tumors in patients with pelvic masses.
    Chen DX, Schwartz PE, Li XG, Yang Z.
    Obstet Gynecol; 1988 Jul; 72(1):23-7. PubMed ID: 3164105
    [Abstract] [Full Text] [Related]

  • 4. Serum CA 125 levels in preoperative evaluation of pelvic masses.
    Vasilev SA, Schlaerth JB, Campeau J, Morrow CP.
    Obstet Gynecol; 1988 May; 71(5):751-6. PubMed ID: 3162763
    [Abstract] [Full Text] [Related]

  • 5. Serum CA 125 levels in a group of nonhospitalized women: relevance for the early detection of ovarian cancer.
    Zurawski VR, Broderick SF, Pickens P, Knapp RC, Bast RC.
    Obstet Gynecol; 1987 Apr; 69(4):606-11. PubMed ID: 2434895
    [Abstract] [Full Text] [Related]

  • 6. Relationship of serum CA125 and lipid-associated sialic acid tumor-associated antigen levels to the disease status of patients with gynecologic malignancies.
    Stratton JA, Rettenmaier MA, Phillips HB, Herabutya S, DiSaia PJ.
    Obstet Gynecol; 1988 Jan; 71(1):20-6. PubMed ID: 2827081
    [Abstract] [Full Text] [Related]

  • 7. Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses.
    O'Connell GJ, Ryan E, Murphy KJ, Prefontaine M.
    Obstet Gynecol; 1987 Dec; 70(6):930-2. PubMed ID: 3479735
    [Abstract] [Full Text] [Related]

  • 8. Preoperative serum tumor-associated antigen levels in women with pelvic masses.
    Soper JT, Hunter VJ, Daly L, Tanner M, Creasman WT, Bast RC.
    Obstet Gynecol; 1990 Feb; 75(2):249-54. PubMed ID: 2300353
    [Abstract] [Full Text] [Related]

  • 9. Relationship between saliva and serum CA 125 in women with and without epithelial ovarian cancer.
    Plante M, Wong GY, Nisselbaum JS, Almadrones L, Hoskins WJ, Rubin SC.
    Obstet Gynecol; 1993 Jun; 81(6):989-92. PubMed ID: 8497368
    [Abstract] [Full Text] [Related]

  • 10. Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease.
    Malkasian GD, Knapp RC, Lavin PT, Zurawski VR, Podratz KC, Stanhope CR, Mortel R, Berek JS, Bast RC, Ritts RE.
    Am J Obstet Gynecol; 1988 Aug; 159(2):341-6. PubMed ID: 2457318
    [Abstract] [Full Text] [Related]

  • 11. [Clinical evaluation of serum CA-50 and CA 19-9 in gynecological tumors].
    Suzuki M, Ohwada M, Tamada T, Sakurabayashi I, Kawai T.
    Rinsho Byori; 1989 Jul; 37(7):784-8. PubMed ID: 2558243
    [Abstract] [Full Text] [Related]

  • 12. Comparison of serum CA 125, clinical impression, and ultrasound in the preoperative evaluation of ovarian masses.
    Finkler NJ, Benacerraf B, Lavin PT, Wojciechowski C, Knapp RC.
    Obstet Gynecol; 1988 Oct; 72(4):659-64. PubMed ID: 3047614
    [Abstract] [Full Text] [Related]

  • 13. CA125 antigen levels in obstetric and gynecologic patients.
    Niloff JM, Knapp RC, Schaetzl E, Reynolds C, Bast RC.
    Obstet Gynecol; 1984 Nov; 64(5):703-7. PubMed ID: 6208522
    [Abstract] [Full Text] [Related]

  • 14. Role of Ca 125 as tumor marker in ovarian carcinoma.
    Krebs HB, Goplerud DR, Kilpatrick SJ, Myers MB, Hunt A.
    Obstet Gynecol; 1986 Apr; 67(4):473-7. PubMed ID: 3008052
    [Abstract] [Full Text] [Related]

  • 15. [Diagnostic significance of preoperative determination of CA-125 serum levels in the differentiation of malignant and benign pelvic masses].
    Durdević S, Segedi D, Vejnović T, Radeka G.
    Med Pregl; 1992 Apr; 45(7-8):262-5. PubMed ID: 1344453
    [Abstract] [Full Text] [Related]

  • 16. Tumor-associated antigen Ca 125 before and during the treatment of ovarian carcinoma.
    Kivinen S, Kuoppala T, Leppilampi M, Vuori J, Kauppila A.
    Obstet Gynecol; 1986 Apr; 67(4):468-72. PubMed ID: 3008051
    [Abstract] [Full Text] [Related]

  • 17. [A monoclonal antibody RIA as an antigenic determinant (CA 125) in ovarian cancer patients].
    Lian LJ.
    Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):257-60, 317. PubMed ID: 2417787
    [No Abstract] [Full Text] [Related]

  • 18. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.
    Bast RC, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parker L, Zurawski VR, Knapp RC.
    N Engl J Med; 1983 Oct 13; 309(15):883-7. PubMed ID: 6310399
    [Abstract] [Full Text] [Related]

  • 19. CA 195: a new monoclonal antibody-defined Lea blood group-related tumor marker in patients with epithelial ovarian cancer.
    Gadducci A, Ferdeghini M, Prontera C, Moretti L, Pellagatta L, Bianchi R, Fioretti P.
    J Nucl Biol Med (1991); 1991 Oct 13; 35(1):33-7. PubMed ID: 1657201
    [Abstract] [Full Text] [Related]

  • 20. [Serum levels and clinical evaluation of CA 19-9 in various diseases].
    Toyama K, Noto M, Sakaguchi T, Adachi K, Mitomi H, Okada N, Ootaka H, Nakazawa H, Hara E.
    Gan No Rinsho; 1985 Mar 13; 31(3):293-8. PubMed ID: 2582158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.